X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Wockhardt Fact Sheet, Wockhardt Financial Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Wockhardt Fact Sheet   (WOCK)

Here is the latest financial fact sheet of Wockhardt. For more details, see the Wockhardt quarterly results and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.

WOCKHARDT LTD. Price History

Price Rs 905.2
Mkt Cap Rs m 99,603
Vol '000 217.3
P/E X -18.2
P/CF X -129.2
EPS (TTM) Rs -49.8
% ch % -1.0
No. of shares m 110.04
% ch week % -4.7
% ch 1-mth % 15.1
% ch 12-mth % 32.0
52 week H/L Rs 1,012.0/531.5
(As on Jan 19, 2018 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

WOCKHARDT LTD. Financials

No. of Mths
Year Ending
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
5-Yr Chart
Click to enlarge
WOCKHARDT LTD. EQUITY SHARE DATA
High Rs2,1662,0701,9802,0001,129 
Low Rs598337455706627 
Sales per share (Unadj.) Rs511.9440.1407.2403.0363.1 
Earnings per share (Unadj.) Rs145.576.636.822.8-20.4 
Diluted earnings per shareRs144.976.436.822.9-20.5 
Cash flow per share (Unadj.) Rs156.689.450.035.7-7.0 
Dividends per share (Unadj.) Rs5.0010.0020.00010.00 
Adj. dividends per shareRs4.989.9720.010.0010.05 
Dividend yield (eoy) %0.40.81.601.1 
Book value per share (Unadj.) Rs219.5299.1335.1341.6301.8 
Adj. book value per shareRs218.6298.3335.2343.1303.2 
Shares outstanding (eoy) m109.58109.75110.07110.51110.55 
Bonus/Rights/Conversions  ESOPESOPESOP-IS 
Price / Sales ratio x2.72.73.03.42.4 
Avg P/E ratio x9.515.733.159.3-42.9 
P/CF ratio (eoy) x8.813.524.337.9-125.9 
Price / Book Value ratio x6.34.03.64.02.9 
Dividend payout %3.413.154.40-48.9 
Avg Mkt Cap Rs m151,429132,062133,983149,50997,063 
No. of employees `000NA8.66.87.46.8 
Total wages/salary Rs m6,5597,6868,6899,5089,665 
Avg. sales/employee Rs ThNM5,616.76,557.76,037.25,931.8 
Avg. wages/employee Rs ThNM893.81,271.41,289.01,428.1 
Avg. net profit/employee Rs ThNM977.6592.5342.0-334.0 
WOCKHARDT LTD. INCOME DATA
Net Sales Rs m56,09448,30444,81544,53040,146 
Other income Rs m5123846666611,143 
Total revenues Rs m56,60648,68845,48145,19141,289 
Gross profit Rs m20,62510,2577,0944,942128 
Depreciation Rs m1,2211,3991,4541,4191,489 
Interest Rs m2,1548345521,2902,253 
Profit before tax Rs m17,7628,4085,7532,895-2,472 
Minority Interest Rs m0-21-7860 
Prior Period Items Rs m-60000 
Extraordinary Inc (Exp) Rs m767498000 
Tax Rs m2,5824791,627379-211 
Profit after tax Rs m15,9418,4074,0492,522-2,260 
Gross profit margin %36.821.215.811.10.3 
Effective tax rate %14.55.728.313.18.5 
Net profit margin %28.417.49.05.7-5.6 
WOCKHARDT LTD. BALANCE SHEET DATA
Current assets Rs m33,26933,55934,63739,51946,160 
Current liabilities Rs m17,73517,43217,75218,41919,258 
Net working cap to sales %27.733.437.747.467.0 
Current ratio x1.91.92.02.12.4 
Inventory Days Days69758390101 
Debtors Days Days6236539194 
Net fixed assets Rs m24,80530,02233,90937,36940,165 
Share capital Rs m548549550553553 
"Free" reserves Rs m21,53128,21936,33237,19932,814 
Net worth Rs m24,05632,82936,88337,75133,367 
Long term debt Rs m14,75211,02314,27019,20631,903 
Total assets Rs m60,22766,22071,71581,20989,687 
Interest coverage x9.211.111.43.2-0.1 
Debt to equity ratio x0.60.30.40.51.0 
Sales to assets ratio x0.90.70.60.50.4 
Return on assets %30.014.06.44.70 
Return on equity %66.325.611.06.7-6.8 
Return on capital %53.322.212.27.4-0.3 
Exports to sales %20.912.810.011.60 
Imports to sales %5.17.86.24.50 
Exports (fob) Rs m11,7406,1804,4715,1770 
Imports (cif) Rs m2,8433,7602,7731,9900 
Fx inflow Rs m14,58211,02610,7407,5899,121 
Fx outflow Rs m3,6244,3613,3562,8782,133 
Net fx Rs m10,9596,6657,3834,7116,988 
WOCKHARDT LTD. CASH FLOW
From Operations Rs m 15,324 14,763 3,550 716 -2,695 
From Investments Rs m 10,854 -8,516 -2,066 -8,182 -6,863 
From Financial Activity Rs m -22,458 -6,013 -757 2,543 12,545 
Net Cashflow Rs m 3,720 234 727 -4,941 3,010 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 74.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 2.3%
FIIs 7.7%
ADR/GDR 0.1%
Free float 15.4%
Shareholders 67,757
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Wockhardt Towers, C/2-G Block, BKC, Bandra (E), Mumbai-400 051
E-MAIL investorrelations@wockhardt.com WEB www.wockhardt.com
TELEPHONE (022) 2653 4444 FAX (022) 2652 3905
SECTOR PHARMACEUTICALS GROUP KHORAKIWALA
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Haribhakti & Co.
CHM: Habil Khorakiwala COMP SEC: V. R. Khetan YEAR OF INC: 1973 BSE CODE: 532300 FV (Rs): 5 DIV YIELD (%): 1.1

More Pharmaceuticals Company Fact Sheets:   SHASUN PHARMA  PFIZER  INDOCO REMEDIES  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare WOCKHARDT LTD. With:   SHASUN PHARMA  PFIZER  INDOCO REMEDIES  TORRENT PHARMA  ORCHID PHARMA LTD  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Views on news

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - PANACEA BIOTECH COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS